Abstract
Objective
Gallbladder cancer (GBC) is a rare gastrointestinal malignancy. A retrospective population-based study was conducted to evaluate trends in incidence, treatment, and outcome of GBC in the latter three decades in the south of the Netherlands.
Methods
All patients diagnosed with GBC diagnosed in the Dutch Eindhoven Cancer Registry area between 1975 and 2008 were included (n = 659). Trend analyses were conducted for treatment and survival.
Results
During this time period, standardized incidence in females and males plummeted from 4.5 to 0.7 and from 2.0 to 0.4 per 100,000 inhabitants, respectively. Resection rates decreased from 74.3 to 53.4 %. Chemotherapy and radiotherapy rates did not change and were used sparingly. Five-year survival remained stable (10 %) over time.
Conclusion
The age-standardized incidence of GBC declined drastically over the last three decades. An increasing number of early cholecystectomies for gallstones may play a role. Parallel to the decreasing incidence of stomach cancer, the effective treatment of Helicobacter pylori may also have resulted in a lowered incidence of GBC.
Similar content being viewed by others
References
Randi G, Malvezzi M, Levi F, Ferlay J, Negri E, Franceschi S et al (2009) Epidemiology of biliary tract cancers: an update. Ann Oncol 20(1):146–159
Varshney S, Butturini G, Gupta R (2002) Incidental carcinoma of the gallbladder. Eur J Surg Oncol 28(1):4–10
Saika K, Matsuda T (2007) Comparison of time trends in gallbladder cancer incidence (1973–1997) in East Asia, Europe and the USA, from cancer incidence in five continents vols IV–VIII. Jpn J Clin Oncol 37(12):974–976
Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46(4):765–781
Available from: www.ikcnet.nl
Cubertafond P, Gainant A, Cucchiaro G (1994) Surgical treatment of 724 carcinomas of the gallbladder. Results of the french surgical association survey. Ann Surg 219(3):275–280
Kayahara M, Nagakawa T (2007) Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients. Cancer 110(3):572–580
Schouten LJ, Hoppener P, van den Brandt PA, Knottnerus JA, Jager JJ (1993) Completeness of cancer registration in Limburg, The Netherlands. Int J Epidemiol 22(3):369–376
Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (eds) (1997) Cancer incidence in five continents, vol VII. IARC Scientific Publications No. 143, Lyon, IARC
Harmer MH (1978) TNM classification of malignant tumours, 3rd edn. International Union Against Cancer, Geneva
Globocan 2008 (2008) World health organization. Available from: http://globocan.iarc.fr/
Hoogendoorn D (1988) Remarkable changes in the epidemiological pattern of gallstone disease and gallbladder cancer. Ned Tijdschr Geneeskd 132(27):1243–1248
Kiran RP, Pokala N, Dudrick SJ (2007) Incidence pattern and survival for gallbladder cancer over three decades—an analysis of 10301 patients. Ann Surg Oncol 14(2):827–832
Barakat J, Dunkelberg JC, Ma TY (2006) Changing patterns of gallbladder carcinoma in New Mexico. Cancer 106(2):434–440
Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II et al (2001) Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 51(6):349–364
van der Hoeven J, Busch O, Bijnen C, Gouma D, van Gulik T (2010) Diagnosis and treatment of carcinoma of the gall bladder. Ned Tijdschr Geneeskd 154:A355
Fujita N, Noda Y, Kobayashi G, Kimura K, Yago A (1999) Diagnosis of the depth of invasion of gallbladder carcinoma by EUS. Gastrointest Endosc 50(5):659–663
Legorreta AP, Silber JH, Costantino GN, Kobylinski RW, Zatz SL (1993) Increased cholecystectomy rate after the introduction of laparoscopic cholecystectomy. JAMA 270(12):1429–1432
Ahlberg J, Bergstrand LO, Sahlin S (1984) Changes in gallstone morbidity in a community with decreasing frequency of cholecystectomies. A statistical study of the county of Stockholm, Sweden, 1969–1982. Acta Chir Scand Suppl 520:53–58
Diehl AK, Beral V (1981) Cholecystectomy and changing mortality from gallbladder cancer. Lancet 2(8239):187–189
Statistics Netherlands CBS Statline. Available from: www.cbs.nl
Maurer KJ, Ihrig MM, Rogers AB, Ng V, Bouchard G, Leonard MR et al (2005) Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology 128(4):1023–1033
Leong RW, Sung JJ (2002) Review article: helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 16(6):1037–1045
Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ et al (2010) Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer 46(6):1101–1110
Hansen S, Vollset SE, Derakhshan MH, Fyfe V, Melby KK, Aase S et al (2007) Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut 56(7):918–925
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M et al (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345(11):784–789
Pinheiro PS, van der Heijden LH, Coebergh JW (1999) Unchanged survival of gastric cancer in the southeastern Netherlands since 1982: result of differential trends in incidence according to Laurén type and subsite. Int J Cancer 84(1):28–32
Belzer C, Kusters JG, Kuipers EJ, van Vliet AH (2006) Urease induced calcium precipitation by Helicobacter species may initiate gallstone formation. Gut 55(11):1678–1679
Maurer KJ, Rao VP, Ge Z, Rogers AB, Oura TJ, Carey MC et al (2007) T-cell function is critical for murine cholesterol gallstone formation. Gastroenterology 133(4):1304–1315
Wistuba II, Gazdar AF (2004) Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer 4(9):695–706
Jergens AE, Wilson-Welder JH, Dorn A, Henderson A, Liu Z, Evans RB et al (2007) Helicobacter bilis triggers persistent immune reactivity to antigens derived from the commensal bacteria in gnotobiotic C3H/HeN mice. Gut 56(7):934–940
Fong Y, Jarnagin W, Blumgart LH (2000) Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention. Ann Surg 232(4):557–569
Dixon E, Vollmer CM Jr, Sahajpal A, Cattral M, Grant D, Doig C et al (2005) An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg 241(3):385–394
Zhu AX, Hong TS, Hezel AF, Kooby DA (2010) Current management of gallbladder carcinoma. Oncologist 15(2):168–181
Thomas MB (2008) Targeted therapies for cancer of the gallbladder. Curr Opin Gastroenterol 24(3):372–376
Carriaga MT, Henson DE (1995) Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 75(1 Suppl):171–190
Aldridge MC, Bismuth H (1990) Gallbladder cancer: the polyp-cancer sequence. Br J Surg 77(4):363–364
Mayo SC, Shore AD, Nathan H, Edil B, Wolfgang CL, Hirose K et al (2010) National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis. J Gastrointest Surg 14(10):1578–1591
Konstantinidis IT, Deshpande V, Genevay M, Berger D, Fernandez-del Castillo C, Tanabe KK et al. (2009) Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg 144(5):441–447. Discussion 7
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Alexander, S., Lemmens, V.E.P.P., Houterman, S. et al. Gallbladder cancer, a vanishing disease?. Cancer Causes Control 23, 1705–1709 (2012). https://doi.org/10.1007/s10552-012-0049-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-012-0049-0